Chromatography processes for mAb variants: mAbs, bsAbs, Fabs, dAbs, and more

Antibodies are the largest class of biotherapeutics, over the year development beyond traditional monoclonal antibodies (mAbs) has increased.
Molecules like bispecific antibodies, antibody fragments are leading to new treatments to help patients.
Purification platforms used for many mAbs needs to be adopted for antibody variants to simplify protocols and improve purity and yield.
In this video, we explain what to consider then setting up purification protocols for antibody variants.
Find out more on cytiva.link/vpxg4